68Ga PSMA-11 PET With CT Urography Protocol in the Initial Staging and Biochemical Relapse of Prostate Cancer

Cancer Imaging - United Kingdom
doi 10.1186/s40644-017-0133-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Scientific Reports
Multidisciplinary
2020English

(OA35) Impact of Staging 68Ga-Psma-11 Pet Scans on Radiation Treatment Plans in Patients With Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

68Ga‐PSMA‐11 PET‐CT Study in Prostate Cancer Patients With Biochemical Recurrence and Non‐contributive 18F‐Choline PET‐CT: Impact on Therapeutic Decision‐making and Biomarker Changes

Prostate
OncologyUrology
2018English

68Ga-Psma-11 PET/CT in Primary Staging of Prostate Carcinoma: Preliminary Results on Differences Between Black and White South-Africans

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Actual Impact Of68Ga-Psma-11 PET/CT on the Management of Prostate Cancer Patients With Biochemical Recurrence

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

68Ga-Psma Ligand PET/CT in Patients With Prostate Cancer: How We Review and Report

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2016English

Diagnostic Performance of 68Ga-Psma-11 (HBED-CC) PET/CT in Patients With Recurrent Prostate Cancer: Evaluation in 1007 Patients

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Interobserver Variability, Detection Rate, and Lesion Patterns of 68Ga-Psma-11-Pet/Ct in Early-Stage Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2020English

Prognostic Risk Classification for Biochemical Relapse-Free Survival in Patients With Oligorecurrent Prostate Cancer After [68Ga]PSMA-Pet-Guided Metastasis-Directed Therapy

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy